2020 ASCO Virtual Direct™ Highlights

 

2020 ASCO Virtual Direct™ Highlights
Avatar

2020 ASCO Update on Resectable Stage III Melanoma: Can We Avoid TLND With Neoadjuvant Ipilimumab + Nivolumab?

By 2020 ASCO Virtual Direct™ Highlights FEATURING Marlana Orloff
By 2020 ASCO Virtual Direct™ Highlights FEATURING Marlana Orloff
54 views
August 20, 2020
0 Comments
Login to view comments. Click here to Login

Featured Video

03:38
Lilly Medical Affairs

SERDS: Relevance and Role in Current & Future Treatments for HR+…

Feat. K. Jhaveri

Featured Video

06:40
Lilly Medical Affairs

Communicating the Risk of Recurrence for Patients With HR+, HER2- Ea…

Feat. J. O’Shaughnessy
Skin
12:19

2020 ASCO Highlights on Melanoma: How Effective Is the Combination o…

2020 ASCO Virtual Direct™ Highlights

M. Orloff

85 views
08:06

2020 ASCO Update on Resectable Stage III Melanoma: Can We Avoid TLND…

2020 ASCO Virtual Direct™ Highlights

M. Orloff

54 views
04:41

2020 ASCO Follow Up on Advanced Melanoma: Should We Consider TIL as …

2020 ASCO Virtual Direct™ Highlights

M. Orloff

41 views
13:04

2020 ASCO Update on Metastatic Melanoma: Is Toripalimab + Axitinib a…

2020 ASCO Virtual Direct™ Highlights

M. Orloff

21 views